Saturday, August 16, 2014 1:13:37 PM
Don Dion Aug. 15, 2014 2:40 PM ET
Click For seekingalpha.com Article
Summary
The 40 day quiet period for SYF will conclude September 8, allowing SYF’s IPO underwriters to publish (likely positive) analyses of the GE consumer financial services spinoff.
This event could lead to positive, above-market returns for SYF in the days surrounding the quiet period expiration—a phenomena tracked in academia and our own research.
Though SYF got off to a rocky start, we remain optimistic on SYF moving forward, given impressive revenues and consumer spending moving in a positive direction.
The upcoming quiet period expiration may help to galvanize potential investors and present a strong buying opportunity.
Synchrony Financial (NYSE:SYF) - Buy Recommendation - PT $23.75
The 40 day quiet period on underwriter reports that began with the July 30 IPO of Synchrony Financial will conclude on September 8, allowing the IPO underwriters to publish analyses of the GE (NYSE:GE) consumer financial services spinoff. SYF share prices will likely rise temporarily with the release of the underwriter analyses.
Early Market Performance: Boost on the Horizon
SYF's IPO priced at the low end of its expected price range at $23 per share on an overcrowded day of IPOs and has seen little change since, closing at its IPO price on August 12. August 13, however, saw a jump to $23.18.
(Nasdaq.com)
Impressive Underwriting Roster
For more,please visit site:
TRUTH
I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of solutions.
Recent SYF News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 08:33:49 PM
- Synchrony Extends Partnership with Affordable Care Offering CareCredit to Patients • PR Newswire (US) • 05/02/2024 01:00:00 PM
- Synchrony and ServiceTitan Join Forces to Streamline Home Improvement Financing • PR Newswire (US) • 04/30/2024 01:00:00 PM
- Synchrony Reports First Quarter 2024 Results; Company also Announces Quarterly Stock Dividends and Approval of an Incremental $1.0 Billion Share Repurchase Program • PR Newswire (US) • 04/24/2024 10:13:00 AM
- Synchrony Expands Dental Payment Offerings with Adit Practice Management Software Partnership • PR Newswire (US) • 04/18/2024 01:00:00 PM
- Synchrony Partners with BRP to Provide Retail Financing Options in the United States • PR Newswire (US) • 04/08/2024 01:00:00 PM
- SYNCHRONY RECOGNIZED FOR ITS PEOPLE-CENTRIC CULTURE WITH NEW COMPANY RANKING • PR Newswire (US) • 04/04/2024 12:38:00 PM
- Synchrony to Announce First Quarter 2024 Financial Results on April 24, 2024 • PR Newswire (US) • 03/26/2024 12:00:00 PM
- Skipify and Synchrony Enter into Strategic Partnership to Simplify and Enhance Online Checkout • PR Newswire (US) • 03/13/2024 01:00:00 PM
- IPH ENTERS STRATEGIC PARTNERSHIP WITH SYNCHRONY AND COMPLETES ACQUISITION OF PETS BEST • PR Newswire (US) • 03/06/2024 04:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:30:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:30:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:29:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:29:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:29:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:29:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:28:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:28:41 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 10:24:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 09:40:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 09:00:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 08:45:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 06:52:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 05:41:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 01:30:44 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM